Stock comparison
JOHNSON & JOHNSON is 869.1x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($663.28 B vs $763.17 M). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 869.1x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($663.28 B vs $763.17 M).
Market value leader
JNJ
JOHNSON & JOHNSON is 869.1x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($663.28 B vs $763.17 M).
Revenue leader
JNJ
COLL: $780.57M vs JNJ: $94.19B.
Profit leader
JNJ
COLL: $63.00M vs JNJ: $26.80B.
Margin leader
JNJ
COLL: 8.1% vs JNJ: 28.5% net margin.
| Metric | COLL | JNJ |
|---|---|---|
| Market cap | $763.17 M | $663.28 B |
| US-listed rank | #2642 | #16 |
| Revenue (latest FY) | $780.57M | $94.19B |
| Net income (latest FY) | $63.00M | $26.80B |
| Net margin | 8.1% | 28.5% |
| P/E (trailing FY) | 12.1x | 24.7x |
| SEC filings | 846 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 869.1x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($663.28 B vs $763.17 M).
In their latest fiscal years, COLLEGIUM PHARMACEUTICAL, INC reported $780.57M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: COLLEGIUM PHARMACEUTICAL, INC and JOHNSON & JOHNSON, or browse the full rankings.